What is Neurocrine Biosciences's investment proceeds?

Neurocrine Biosciences (NBIX) reported investment proceeds of $259.2M in Q1 2026.

How has Neurocrine Biosciences's investment proceeds changed year-over-year?

Neurocrine Biosciences's investment proceeds decreased by 13.0% year-over-year, from $298.1M to $259.2M.

What is the long-term trend for Neurocrine Biosciences's investment proceeds?

Over 4 years (2021 to 2025), Neurocrine Biosciences's investment proceeds has grown at a 11.8% compound annual growth rate (CAGR), from $697.9M to $1.09B.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Neurocrine Biosciences NBIX Investment Proceeds

Investment Proceeds at other companies

BridgeBio PharmaBBIO

$10M—

Ionis PharmaceuticalsIONS

$752.82M+52.2%

Arrowhead ResearchARWR

$115.34M-2.4%

BiogenBIIB

$500K—

AlkermesALKS

$42.61M-62.5%

Rhythm Pharmaceuticals, Inc.RYTM

——

Other financials

Income statement

See full

Revenue$814.5M+42.2%

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

Net income$197.9M+2,405%

EPS (diluted)$1.91+2,287%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Total assets$4.9B+33.0%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$15.92B+19.9%

Enterprise value$16.11B+18.5%

P/E23.8×-19.6×

P/S5.1×-0.4×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

FCF margin26.8%+6.4pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's investment proceeds?: Neurocrine Biosciences (NBIX) reported investment proceeds of $259.2M in Q1 2026.
How has Neurocrine Biosciences's investment proceeds changed year-over-year?: Neurocrine Biosciences's investment proceeds decreased by 13.0% year-over-year, from $298.1M to $259.2M.
What is the long-term trend for Neurocrine Biosciences's investment proceeds?: Over 4 years (2021 to 2025), Neurocrine Biosciences's investment proceeds has grown at a 11.8% compound annual growth rate (CAGR), from $697.9M to $1.09B.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.